Tag Archives: FDA

Tekmira Pharmaceuticals Ebola Drug Gets Nod From FDA

BIO Investor Forum

The U.S. Food and Drug Administration has authorized Canada’s Tekmira Pharmaceuticals to provide an experimental drug to people with confirmed or suspected Ebola virus infections, according to an article in The Wall Street Journal. “Our TKM-Ebola drug supplies are limited, but we will continue to help where we can,” Tekmira Chief Executive Mark J. Murray said in a press release. The drug is still in clinical testing to assess whether it is safe and effective. BIO Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Patients Suffering from Gaucher’s Disease Deserve Better

scientist-eyedropper

Gaucher Disease is one of the over 6,000 rare diseases that affect patients worldwide, representing a frontier of unmet medical need [NCATS, NIH]. The challenges for drug development generally—long and costly research and development timelines—are exacerbated by the inherently small patient populations affected by rare diseases. These patients can be difficult to identify and geographically dispersed and their clinical presentation can be quite disparate, complicating the design and recruitment for clinical trials used to determine Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Pro-GMO Labeling Business Faces Own Labeling Dilemma

FDA115x76

 “Dr. Bronner’s should spend more time worrying about their own labels.” The Center for Consumer Freedom recently published an interesting piece on Dr. Bronner’s Magic Soaps and his run in with the FDA.  You may know that Dr. Bronner’s Magic Soaps is an outspoken advocate of the scientifically suspect “GMO labeling” movement.  In a warning letter to the company, the FDA states: “Based on our review of the product label, we have determined that your product is promoted for conditions that Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Docs to FDA: Biosimilars should have different names than branded drugs

shutterstock_1092009

Yesterday, Fierce Biotech highlighted a letter written by more than 10 medical associations and 20 individual specialists to FDA Commissioner Margaret Hamburg saying that biosimilars “must have distinguishable nonproprietary names. The FDA drafted a set of rules for biosimilars in 2012, sparking a debate on whether those drugs should carry the same generic names as the originator products. Now, some doctors are weighing in on the issue, urging the FDA to require biosimilars to have distinguishable names. The physicians argued that using different Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

The “Other Issues to Worry About” vs. GMO’s

shutterstock_27291016

We don’t label foods for pesticides, fertilizers or these other “conventional” food-production technologies. Only genetically engineered food is considered unconventional; it’s what the big labeling-law movement is all about these days. Why is that? Largely because groups of people have managed to make it an issue, not because it’s the one big dangerous thing happening with our food – The LA Times, Karin Klein Last week, the Los Angeles Times released an opinion blog with Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,